Cydy sec filings

Author: gkms

August undefined, 2024

WebApr 12, 2024 · CYDY CytoDyn Inc: Wall Street is to the SEC what Big Pharma is to the FDA, but on a tiny scale. Not a conspiracy, bu - #6560037 WebFeb 28, 2024 · Fiscal Year Ended May 31, 2024. 10-K Filing. PDF HTML

Cytodyn Inc. (CYDY) 10-K Annual Report July 2024

WebAug 15, 2024 · SEC gov • August 15, 2024. CYDY : 10-K Annual report pursuant to Section 13 and 15(d) Symbol. CYDY. ... Related Filings from CYDY. 8-K Current report filing. Mar 08, 2024. WebMay 31, 2024 · ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. ... Generally, patents issued in the U.S. are effective for either (i) 20 years from the earliest asserted filing date, if the application was filed on or after June 8, 1995, or (ii) the longer of 17 years from the date of issue or 20 … flintstones chewable multivitamin

Cytodyn Inc. (CYDY) 10-Q Quarterly Report April 2024

WebApr 10, 2024 · Latest SEC filings for CytoDyn Inc. (CYDY). If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. WebJul 19, 2024 · Cytodyn Inc (CYDY) SEC Filings Nasdaq SEC Filings: CYDY Edit my quotes Cytodyn Inc (CYDY) 0 No Notifications Add to Watchlist Add to Portfolio Quotes … WebJan 9, 2024 · SEC.gov Filings & Forms Filings & Forms All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR. Anyone can access and download this information for free. flintstones chewable multivitamin with iron

Yahoo Finance - Stock Market Live, Quotes, Business & Finance …

Recent 13D Filings for CytoDyn Inc. (CYDY) - Insider monitor

Web11 rows · Current report filing. 4. 02/14/23. 4. Statement of changes in beneficial ownership of securities. 1. 02/09/23. CytoDyn is a publicly traded late stage biotechnology company developing … WebCytoDyn Inc. focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. The company was formerly known as RexRay Corporation. Formally known as: CytoDyn Inc. View SEC Filings from CYDY instead. Refresh Summary Table View recent insider … greater spotted woodpecker fledglingWebCYDY / CytoDyn Inc - SEC Filings, Annual Report, Proxy Statement EXTENDED Overview Owners Insiders Short Interest Filings Financials Dividends Earnings Forecast SEC … flintstones chewable nutrition facts

"WebJul 2, 2024 · Since 2024, there have been 4 Schedule 13D forms (beneficial ownership report) filed for the company CytoDyn Inc. (stock symbol CYDY) by 3 beneficial owners. A schedule 13D is filed when a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company's equity securities. " - Cydy sec filings

Cydy sec filings

Quarterly Reports :: CytoDyn Inc. (CYDY)

WebApr 10, 2024 · Cytodyn Inc. (CYDY) SEC Filing 10-Q Quarterly Report for the period ending Tuesday, February 28, 2024. ... Cytodyn Inc. (CYDY) 10-Q Quarterly Report Mon Apr 10 2024; SEC Filings. CYDY Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. Manager Portfolios. Notifications. CYDY Annual Reports. 10-K Annual … WebSection 16 Filings Filing Type: View All 10-K 10-K/A 10KSB 10KSB/A ARS NT 10-K Year: View All 2024 2024 2024 2024 2024 2024 2024 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002

Did you know?

WebAug 31, 2024 · SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2024 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1933 … WebApr 10, 2024 · A high-level overview of CytoDyn Inc. (CYDY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. ... SEC Filings. Type: All.

WebJul 2, 2024 · Since 2024, there have been 4 Schedule 13D forms (beneficial ownership report) filed for the company CytoDyn Inc. (stock symbol CYDY) by 3 beneficial owners. … WebJan 10, 2024 · Ticker: CYDY CIK: 1175680 Form Type: 10-Q Quarterly Report Accession Number: 0001558370-22-000190 Submitted to the SEC: Mon Jan 10 2024 5:12:18 PM EST Accepted by the SEC: Mon Jan 10 2024 Period: Tuesday, November 30, 2024 Industry: Pharmaceutical Preparations External Resources: Stock Quote Social Media Bookmark …

WebSection 16 Filings Filing Type: View All 10-Q 10-Q/A 10QSB 10QSB/A NT 10-Q Year: View All 2024 2024 2024 2024 2024 2024 2024 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Web02/09/23. EFFECT. Notice of Effectiveness. 1. 02/03/23. POS AM. Post-effective amendment to a registration statement that is not immediately effective upon filing.

WebApr 10, 2024 · table of contents united statessecurities and exchange commissionwashington, dc 20549form quarterly report under section 13 or 15(d) of the securities exchange act of 1934for the

WebJan 9, 2024 · Latest Quarterly or Annual Filing. 10-Q. January 9, 2024. Quarterly report pursuant to Section 13 or 15 (d) greater spotted woodpecker femaleWebJul 27, 2024 · Cytodyn Inc. (CYDY) SEC Filing 10-K Annual report for the fiscal year ending Thursday, May 31, 2024 Home SEC Filings Cytodyn Inc. (CYDY) 10-K Annual Report Fri Jul 27 2024 10-K Annual Report Summary 10-K Annual Report 10-K YoY Changes Cytodyn Inc. CIK: 1175680 Ticker: CYDY GET DIRECTION ON YOUR INVESTMENTS greater spotted woodpecker foodWebApr 11, 2024 · Ticker: CYDY CIK: 1175680 Form Type: 10-Q Quarterly Report Accession Number: 0001558370-22-005291 Submitted to the SEC: Mon Apr 11 2024 5:19:33 PM … flintstones chewable vitaminsWebApr 10, 2024 · Cytodyn Inc. (CYDY) SEC Filing 10-Q Quarterly Report for the period ending Tuesday, February 28, 2024. ... Cytodyn Inc. (CYDY) 10-Q Quarterly Report Mon Apr 10 … flintstones chewable mviWebCytoDyn Inc. focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 … greater spotted woodpecker rspbWebNov 25, 2024 · FEATURED Music Licensing, Inc. (OTC:SONG) Announces Groundbreaking Research and Plans to Develop Proprietary AI Music Technology • Apr 10, 2024 8:30 AM. ILUS Files Its 2024 Annual Report With the SEC, Confirming a 595% Revenue Increase Over 2024 • ILUS • Apr 10, 2024 8:04 AM. M2Bio Appoints Ze-ev Krein as Chairman of … flintstones chewable vitamin ingredientsWebDec 7, 2024 · SEC gov • December 07, 2024 ... Download. Exhibits 8-K EX-10.1. Advertisement. Advertisement. Related Filings from CYDY. 10-Q Quarterly report pursuant to Section 13 or 15(d) Jan 09, 2024. 8-K ... greater spotted woodpecker male